Relapsed or Refractory Multiple Myeloma Multiple myeloma is a type of blood cancer that affects …
Introduction Lorbrena (Lorlatinib) is a prescribed medication designed for the treatment of adul…
Duchenne muscular dystrophy (DMD), a rare genetic disorder impacting 1 in 5,000 male births globall…
Von Hippel-Lindau (VHL) disease has undergone a profound shift with the approval of Welireg, markin…
Oxlumo (Lumasiran) has emerged as the inaugural approved treatment for Primary Hyperoxaluria Type 1…
Retevmo (Selpercatinib), a highly discerning RET inhibitor, has garnered FDA endorsement, emerging …
Gout is a type of arthritis caused by the buildup of uric acid crystals in the joints, leading to i…
Diacomit (stiripentol) is a unique antiseizure medication developed by Biocodex in the 1990s. Stiri…
Tukysa (tucatinib) is a targeted therapy medication used to treat certain advanced-stage HER2-posit…
Trodelvy (sacituzumab govitecan) is an innovative treatment for breast cancer that has shown signif…
Blinatumomab, marketed as Blincyto, is a promising immunotherapy for acute lymphoblastic leukemia (…
Monjuvi (tafasitamab-cxix) presents a promising novel approach to treating diffuse large B cell lym…
Sarclisa (isatuximab-irfc) is a promising new treatment for multiple myeloma, a type of cancer that…
Rozlytrek (entrectinib) is a targeted therapy that has been approved by the FDA for the treatment o…
Enhertu (fam-trastuzumab deruxtecan-nxki) is a promising drug in the field of cancer treatment, par…